Breaking News

Thursday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
CORT

Corcept Therapeutics

$12.46

-0.41 (-3.19%)

, TEVA

Teva

$21.25

0.06 (0.28%)

15:51
10/18/18
10/18
15:51
10/18/18
15:51
Hot Stocks
Corcept slides after Teva gets tentative approval for generic version of Korlym »

An ANDA submitted by Teva…

CORT

Corcept Therapeutics

$12.46

-0.41 (-3.19%)

TEVA

Teva

$21.25

0.06 (0.28%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

TEVA

Teva

$21.27

0.08 (0.38%)

15:03
10/18/18
10/18
15:03
10/18/18
15:03
Hot Stocks
FDA reports tentative approval for Actavis' ANDA for Pimecrolimus »

Actavis is a unit of Teva…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

TEVA

Teva

$21.53

0.34 (1.60%)

, MYL

Mylan

$32.58

-0.45 (-1.36%)

10:25
10/18/18
10/18
10:25
10/18/18
10:25
Recommendations
Teva, Mylan, Amneal Pharmaceuticals, Novartis analyst commentary at Wells Fargo »

Sandoz results…

TEVA

Teva

$21.53

0.34 (1.60%)

MYL

Mylan

$32.58

-0.45 (-1.36%)

AMRX

Amneal Pharmaceuticals

$18.66

0.17 (0.92%)

NVS

Novartis

$86.38

1.04 (1.22%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 19

    Oct

  • 19

    Oct

  • 01

    Nov

  • 07

    Nov

  • 07

    Nov

  • 13

    Nov

  • 28

    Feb

Wednesday
TEVA

Teva

$21.14

-1.115 (-5.01%)

, LLY

Eli Lilly

$112.75

1.72 (1.55%)

12:16
10/17/18
10/17
12:16
10/17/18
12:16
OnTheFly
Teva under pressure as Express Scripts snubs new migraine drug, covers rivals »

Shares of Teva…

TEVA

Teva

$21.14

-1.115 (-5.01%)

LLY

Eli Lilly

$112.75

1.72 (1.55%)

ESRX

Express Scripts

$96.26

0.07 (0.07%)

AMGN

Amgen

$201.02

-1.28 (-0.63%)

NVS

Novartis

$85.35

-0.4 (-0.47%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 17

    Oct

  • 18

    Oct

  • 19

    Oct

  • 19

    Oct

  • 22

    Oct

  • 23

    Oct

  • 30

    Oct

  • 01

    Nov

  • 06

    Nov

  • 07

    Nov

  • 09

    Nov

TEVA

Teva

$20.94

-1.31 (-5.89%)

, ESRX

Express Scripts

$94.94

-1.25 (-1.30%)

10:52
10/17/18
10/17
10:52
10/17/18
10:52
Recommendations
Teva, Express Scripts analyst commentary at Wells Fargo »

Express Scripts decision…

TEVA

Teva

$20.94

-1.31 (-5.89%)

ESRX

Express Scripts

$94.94

-1.25 (-1.30%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

ESRX

Express Scripts

$96.19

2.63 (2.81%)

, AMGN

Amgen

$202.30

6.77 (3.46%)

08:01
10/17/18
10/17
08:01
10/17/18
08:01
Periodicals
Teva migraine therapy excluded from Express Scripts coverage, Reuters reports »

Prescription benefits…

ESRX

Express Scripts

$96.19

2.63 (2.81%)

AMGN

Amgen

$202.30

6.77 (3.46%)

LLY

Eli Lilly

$111.03

0.34 (0.31%)

TEVA

Teva

$22.25

0.51 (2.35%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 17

    Oct

  • 19

    Oct

  • 19

    Oct

  • 22

    Oct

  • 23

    Oct

  • 30

    Oct

  • 01

    Nov

  • 06

    Nov

  • 07

    Nov

  • 09

    Nov

Over a week ago
MYL

Mylan

$32.17

-0.44 (-1.35%)

, TEVA

Teva

$21.42

0.96 (4.69%)

12:36
10/12/18
10/12
12:36
10/12/18
12:36
Hot Stocks
Mylan says it prevails in Copaxone litigation against Teva in appellate court »

Mylan (MYL) announced…

MYL

Mylan

$32.17

-0.44 (-1.35%)

TEVA

Teva

$21.42

0.96 (4.69%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 01

    Nov

  • 13

    Nov

TEVA

Teva

$21.01

0.545 (2.66%)

, MYL

Mylan

$32.64

0.03 (0.09%)

10:33
10/12/18
10/12
10:33
10/12/18
10:33
Periodicals
Court upholds ruling that cancels Teva's Copaxone patents, Reuters reports »

A U.S. appeals court has…

TEVA

Teva

$21.01

0.545 (2.66%)

MYL

Mylan

$32.64

0.03 (0.09%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 01

    Nov

  • 13

    Nov

TEVA

Teva

$21.12

-0.06 (-0.28%)

12:33
10/10/18
10/10
12:33
10/10/18
12:33
Hot Stocks
Teva, Celltrion announce FDA committee unanimously recommends CT-P10 »

Celltrion and Teva…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

TEVA

Teva

$21.06

-0.12 (-0.57%)

11:03
10/10/18
10/10
11:03
10/10/18
11:03
Hot Stocks
Teva presents 25-year safety data from longest continuous trial of Copaxone »

Teva Pharmaceutical…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.